Skip to main content

Floragenex, BDI Ink Crop Research Collaboration

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Plant genomics services company Floragenex will collaborate with BioDiagnostics, a plant seed testing firm, to combine their sequencing, high-throughput screening, and breeding technology offerings.

Under the agreement, Floragenex's customers will be able to use BDI's genotyping and testing services, and BDI's customers will have access to Floragenex's DNA sequencing and molecular marker discovery services.

Eugene, Ore.-based Floragenex said today that the companies will launch their collaboration with projects for customers involved in agronomics and vegetable crop development.

"This collaboration with BDI allows us to apply the Floragenex exclusive RAD LongRead sequencing technology to deliver sequence information in any species that can be converted into useful genotyping assays and diagnostic tests offered through BDI," Floragenex CEO Nathan Lillegard said in a statement.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.